Abstract TH234: Hypertension Control and Therapeutic Inertia
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.th234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Ava Bryan und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Quality improvement programs for hypertension management improve blood pressure (BP) control, defined as < 140/90 mmHg. However, previous studies have not shown improvement in therapeutic inertia (TI), which is a significant barrier to BP control. Our medical center enrolled in the American Medical Association Measure Accurately, Act Rapidly, and Partner with Patients (AMA MAP) BP® program in 2018. We examined change in BP control and TI following the implementation of this quality improvement program over an eight-year period.
Methods
We used electronic health record data from 498,866 primary care visits from 2018-2025 among 52,317 unique patients with a hypertension diagnosis and ≥ 2 visits at one of 16 primary care clinics enrolled in the AMA MAP BP® program. Separate-mixed-effects generalized linear models were used to calculate the prevalence ratios (PR) of BP control and TI during a clinic visit with uncontrolled BP, by year, while adjusting for patient demographics, comorbidities, visit location, the number of antihypertensive classes, and insurance. Margins were used to calculate the adjusted probability of BP control during a clinic visit and of TI during visits with uncontrolled BP by year.
Results
Across the study period, the mean age of patients was 63.4 years (s.d. 12.4); 54.7% were female. Race /ethnicity was self-reported as non-Hispanic white in 59.0%, non-Hispanic black in 20.5%, and Hispanic in 11.7%. Most patients were insured through Medicare (47.1%) and private insurance (43.1%). The adjusted PR of BP control increased with time. The PR of BP control in 2019 vs. 2018 was 1.07 (95% Confidence Interval (CI), 1.06, 1.08) and in 2025 vs. 2018 was 1.19 (95% CI 1.18, 1.20). From 2018 to 2025, the adjusted probability of BP control increased from 70.6% to 84.1% (Figure 1). In contrast, the PR of TI decreased over time. The PR of TI in 2019 vs. 2018 was 0.95 (95% CI, 0.94, 0.96) and in 2025 vs. 2018 was 0.90 (95% CI 0.89, 0.91). The adjusted probability of TI among visits with uncontrolled BP declined from 76.0% to 48.0% (Figure 2).
Conclusion
This study shows that a quality improvement program for hypertension management increases BP control and reduces TI. Changes in BP control and TI may occur gradually, and adequate time is needed to fully assess impact.
Zitieren
APA
Bryan, A., Kramer, H., Stout, E., Probst, B., Fearon, M., Habicht, K., Egan, B. M., & Markossian, T. (2026). Abstract TH234: Hypertension Control and Therapeutic Inertia. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th234
Vancouver
Bryan A, Kramer H, Stout E, Probst B, Fearon M, Habicht K, et al. Abstract TH234: Hypertension Control and Therapeutic Inertia. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th234
BibTeX
@article{Bryan2026,
author = {Bryan, Ava and Kramer, Holly and Stout, Ella and Probst, Beatrice and Fearon, Maureen and Habicht, Katherine and Egan, Brent M and Markossian, Talar},
title = {Abstract TH234: Hypertension Control and Therapeutic Inertia},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.th234}
}
EUVIMED